Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Metformin hydrochloride/rosiglitazone
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Rosiglitazone 1mg / Metformin 500mg tablets
0601023V0AAAAAA
|
Metformin hydrochloride/rosiglitazone | Metformin hydrochloride/rosiglitazone | Endocrine System | No data available |
|
Rosiglitazone 2mg / Metformin 1g tablets
0601023V0AAADAD
|
Metformin hydrochloride/rosiglitazone | Metformin hydrochloride/rosiglitazone | Endocrine System | No data available |
|
Rosiglitazone 2mg / Metformin 500mg tablets
0601023V0AAABAB
|
Metformin hydrochloride/rosiglitazone | Metformin hydrochloride/rosiglitazone | Endocrine System | No data available |
|
Rosiglitazone 4mg / Metformin 1g tablets
0601023V0AAACAC
|
Metformin hydrochloride/rosiglitazone | Metformin hydrochloride/rosiglitazone | Endocrine System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.